Document Detail

Radiofrequency ablation of osteoid osteomas: five years experience.
MedLine Citation:
PMID:  22308631     Owner:  NLM     Status:  In-Process    
The purpose of this study is to retrospectively evaluate the efficacy of radiofrequency ablation as a curative treatment method for benign bone tumours. Twenty-nine osteoid osteomas were treated with radiofrequency ablation. Primary success rate was 89.6% and total secondary success rate was 93.1%. Mean clinical follow-up period was 26.7 months (range: 6-63 months). Statistical analysis of 25 cases of osteoid osteomas with CT follow-up revealed that post-treatment re-ossification does not correlate with clinical outcome (p = 0.14) but is strongly correlated with long-term (> or = 12 months) CT follow-up (p = 0.014). Percutaneous radiofrequency ablation was found to be an effective and safe treatment for osteoid osteomas. CT findings cannot solely differentiate between treatment successes and failures.
Zafiria G Papathanassiou; Theodore Petsas; Dionysios Papachristou; Panagiotis Megas
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta orthopaedica Belgica     Volume:  77     ISSN:  0001-6462     ISO Abbreviation:  Acta Orthop Belg     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2012-02-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985165R     Medline TA:  Acta Orthop Belg     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  827-33     Citation Subset:  IM    
Radiology Department, University Hospital of Patras, Rio, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Methotrexate and post operative complications in patients with rheumatoid arthritis undergoing elect...
Next Document:  Insertion of intramedullary nails from the suprapatellar pouch for proximal tibial shaft fractures. ...